Tumour necrosis factor and cancer (original) (raw)

• Carswell, E. A. et al. An endotoxin-induced serum factor that causes necrosis of tumours. Proc. Natl Acad. Sci. USA 72, 3666–3670 (1975).
  Article CAS PubMed PubMed Central Google Scholar
• Coley, W. B. The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases. Am. J. Med. Sci. 105, 487–511 (1893).
  Article Google Scholar
• Nauts, H. C., Swift, W. E. & Coley, B. L. The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M.D. Reviewed in the light of modern research. Cancer Res. 6, 205–216 (1946).
  CAS PubMed Google Scholar
• Locksley, R. M., Killeen, N. & Lenardo, M. J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487–501 (2001).
  Article CAS PubMed Google Scholar
• Moore, R. et al. Tumour necrosis factor-α deficient mice are resistant to skin carcinogenesis. Nature Med. 5, 828–831 (1999).
  Article CAS PubMed Google Scholar
• Pikarsky, E. et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431, 4461–4466 (2004).
  Article CAS Google Scholar
• Balkwill, F. TNF-α in promotion and progression of cancer. Cancer Metastasis Rev. 25, 409–416 (2006).
  Article CAS PubMed Google Scholar
• Sethi, G., Sung, B. & Aggarwal, B. B. TNF: a master switch for inflammation to cancer. Front. Biosci. 13, 5094–5107 (2008).
  Article CAS PubMed Google Scholar
• Feldmann, M. Development of anti-TNF therapy for rheumatoid arthritis. Nature Rev. Immunol. 2, 364–371 (2002).
  Article CAS Google Scholar
• Sands, B. E. et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N. Engl. J. Med. 350, 876–885 (2004).
  Article CAS PubMed Google Scholar
• Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G. & Tak, P. P. Tumor necrosis factor antagonist mechanisms of action: A comprehensive review. Pharmacol. Therapeut. 117, 244–279 (2008).
  Article CAS Google Scholar
• Madhusudan, S. et al. A phase II study of Etanercept (Enbrel), a tumour necrosis factor-α inhibitor in patients with metastatic breast cancer. Clin. Cancer Res. 10, 6528–6534 (2004).
  Article CAS PubMed Google Scholar
• Madhusudan, S. et al. A phase II study of Ethanercept (ENBREL) a tumour necrosis factor- α inhibitor in recurrent ovarian cancer. J. Clin. Oncol. 23, 5950–5959 (2005).
  Article CAS PubMed Google Scholar
• Harrison, M. L. et al. Tumor necrosis factor α as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose. J. Clin. Oncol. 25, 4542–4549 (2007).
  Article CAS PubMed Google Scholar
• Brown, E. R. et al. A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer. Ann. Oncol. 19, 1340–1346 (2008).
  Article CAS PubMed Google Scholar
• Daniel, D. & Wilson, N. S. Tumor necrosis factor: renaissance as a cancer therapeutic? Curr. Cancer Drug Targets. 8, 124–131 (2008).
  Article CAS PubMed Google Scholar
• Coley, W. B. The treatment of inoperable sarcoma by bacterial toxins (the mixed toxins of the streptococcus erysipelas and the bacillus prodigiosus). Proc. R. Soc. Med. 3 (Surg. Sect), 1–48 (1909).
  Google Scholar
• Hall, S. S. A Commotion in the Blood 21–127 (Henry Holt, New York, 1997).
  Google Scholar
• Coley, W. B. Contribution to the knowledge of sarcoma. Ann. Surg. 14, 199–220 (1891).
  Article CAS PubMed PubMed Central Google Scholar
• Coley, W. B. Late results of the treatment of inoperable sarcoma by the mixed toxins of erysipelas and bacillus prodigiosus. Am. J. Med. Sci. 131, 375–430 (1906).
  Google Scholar
• Coley Nauts, H., Fowler, G. A. & Bogatko, F. H. A review of the influence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man. Acta Med. Scand., 29–97 (1953).
• Gratia, A. & Linz, R. Le phenomenene de Schwartzman dans le sarcome du cobaye. C R. Soc. Biol. 108, 427–428 (1931) (in French).
  Google Scholar
• Shear, M. J. & Perrault, A. Chemical treatment of tumors. IX. Reactions of mice with primary subcutaneous tumors to injection of a hemorrhage-producing bacterial polysaccharide. J. Natl Cancer Inst. 44, 461–476 (1944).
  Google Scholar
• O'Malley, W. E., Achinstein, B. & Shear, M. J. Action of bacterial polysaccharide on tumours. II. Damage of sarcoma 37 by serum of mice treated with serratia marcescens polysaccharide, and induced tolerance. J. Natl Cancer Inst. 29, 1169–1175 (1962).
  CAS Google Scholar
• Granger, G. A. & Kolb, W. P. Lymphocyte in vitro cytotoxicity: mechanisms of immune and non-immune small lymphocyte mediated target L cell destruction. J. Immunol. 101, 111–120 (1968).
  CAS PubMed Google Scholar
• Aggarwal, B. B. et al. Human tumor necrosis factor. Production, purification, and characterisation. J. Biol. Chem. 260, 2345–2354 (1985).
  Article CAS PubMed Google Scholar
• Aggarwal, B. B., Moffat, B. & Harkins, R. N. Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization. J. Biol. Chem. 259, 686–691 (1984).
  Article CAS PubMed Google Scholar
• Aggarwal, B. B., Henzel, W. J., Moffat, B., Kohr, W. J. & Harkins, R. N. Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line. J. Biol. Chem. 260, 2334–2344 (1985).
  Article CAS PubMed Google Scholar
• Aggarwal, B. B., Eessalu, T. E. & Hass, P. E. Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon. Nature 318, 665–667 (1985).
  Article CAS PubMed Google Scholar
• Pennica, D. et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312, 724–729 (1984).
  Article CAS PubMed Google Scholar
• Gray, P. W. et al. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity. Nature 312, 721–724 (1984).
  Article CAS PubMed Google Scholar
• Marmenout, A. et al. Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor. Eur. J. Biochem. 152, 515–522 (1985).
  Article CAS PubMed Google Scholar
• Fransen, L. et al. Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Res. 13, 4417–4429 (1985).
  Article CAS PubMed PubMed Central Google Scholar
• Hahn, T. et al. Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self induction of resistance to this protein. Proc. Natl Acad. Sci. USA 82, 3814–3818 (1985).
  Article CAS PubMed PubMed Central Google Scholar
• Hehlgans, T. & Pfeffer, K. The intriguing biology of the tumor necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 115, 1–20 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Dillon, S. R., Gross, J. A., Ansell, S. M. & Novak, A. J. An APRIL to remember: novel TNF ligands as therapeutic targets. Nature Rev. Drug Discov. 5, 235–242 (2006).
  Article CAS Google Scholar
• Sabbagh, L., Snell, L. M. & Watts, T. H. TNF family ligands define niches for T cell memory. Trends Immunol. 28, 333–339 (2007).
  Article CAS PubMed Google Scholar
• Engelmann, H., Aderka, D., Rubinstein, M., Rotman, D. & Wallach, D. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J. Biol. Chem. 264, 11974–11980 (1989).
  Article CAS PubMed Google Scholar
• Engelmann, H., Novick, D. & Wallach, D. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J. Biol. Chem. 265, 1531–1536 (1990).
  Article CAS PubMed Google Scholar
• Loetscher, H. et al. Molecular cloning and expression of the human 55 KD tumor necrosis factor receptor. Cell 61, 351–359 (1990).
  Article CAS PubMed Google Scholar
• Schall, T. J. et al. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61, 361–370 (1990).
  Article CAS PubMed Google Scholar
• Smith, C. A. et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248, 1019–1023 (1990).
  Article CAS PubMed Google Scholar
• Heller, R. A. et al. Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor. Proc. Natl Acad. Sci. USA 87, 6151–6155 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Beutler, B. A. The role of tumor necrosis factor in health and disease. J. Rheumatol. 26, 16–21 (1999).
  Google Scholar
• Feldmann, M. Many cytokines are very useful therapeutic targets in disease. J. Clin. Invest. 118, 3533–3536 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Elliott, M. J. et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor a (cA2) versus placebo in rheumatoid arthritis. Lancet 344, 1105–1110 (1994).
  Article CAS PubMed Google Scholar
• Brouckaert, P. G. G., Leroux-Roels, G. G., Guisez, Y., Tavernier, J. & Fiers, W. In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma on a syngeneic murine melanoma. Int. J. Cancer 38, 763–769 (1986).
  Article CAS PubMed Google Scholar
• Balkwill, F. R. et al. Human tumour xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. Cancer Res. 46, 3990–3993 (1986).
  CAS PubMed Google Scholar
• Talmadge, J. E. et al. Immunomodulatory properties of recombinant murine and human tumor necrosis factor. Cancer Res. 48, 544–550 (1988).
  CAS PubMed Google Scholar
• Watanabe, N. et al. Synergistic cytotoxic and antitumour effects of recombinant tumour necrosis factor and hyperthermia. Cancer Res. 48, 650–653 (1988).
  CAS PubMed Google Scholar
• Nawroth, P. et al. Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas. J. Exp. Med. 168, 637–647 (1988).
  Article CAS PubMed Google Scholar
• Mantovani, A. & Dejana, E. Cytokines as communication signals between leukocytes and endothelial cells. Immunol. Today 10, 370–375 (1989).
  Article CAS PubMed Google Scholar
• Kettlehut, I. C., Fiers, W. & Goldberg, A. L. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. Proc. Natl Acad. Sci. USA 84, 4273–4277 (1987).
  Article Google Scholar
• Havell, E. A., Fiers, W. & North, R. J. The antitumor function of tumor necrosis factor (TNF). 1. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity. J. Exp. Med. 167, 1067–1085 (1988).
  Article CAS PubMed Google Scholar
• Lienard, D., Ewalenko, P., Delmotte, J.-J., Renard, N. & Lejeune, F. J. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J. Clin. Oncol. 10, 52–60 (1992).
  Article CAS PubMed Google Scholar
• Nooijen, P. T. et al. Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study. Br. J. Cancer 74, 1908–1915 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• de Wilt, J. H. et al. Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats. Br. J. Cancer 80, 161–166 (1999).
  Article CAS PubMed Google Scholar
• van der Veen, A. H. et al. TNF-α augments intratumoural concentrations of doxorubicin in TNF-α-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour efects. Br. J. Cancer 82, 973–980 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Seynhaeve, A. L. et al. Tumor necrosis factor α mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response. Cancer Res. 67, 9455–9462 (2007).
  Article CAS PubMed Google Scholar
• Colotta, F., Peri, G., Villa, A. & Mantovani, A. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. 1. Effectors belong to the monocyte-macrophage lineage. J. Immunol. 132, 936–944 (1984).
  CAS PubMed Google Scholar
• Sugarman, B. J. et al. Recombinant human tumor necrosis factor alpha: effects on proliferation of normal and transformed cells in vitro. Science 230, 943–945 (1985).
  Article CAS PubMed Google Scholar
• Dealtry, G. B., Naylor, M. S., Fiers, W. & Balkwill, F. R. The effect of recombinant human tumour necrosis factor on growth and macromolecular synthesis of human epithelial cells. Exp. Cell Res. 170, 428–438 (1987).
  Article CAS PubMed Google Scholar
• Fransen, L., Van der Heyden, J., Ruysschaert, R. & Fiers, W. Recombinant tumor necrosis factor: its effect and its synergism with interferon-gamma on a variety of normal and transformed human cell lines. Eur. J. Cancer Clin. Oncol. 22, 419–426 (1986).
  Article CAS PubMed Google Scholar
• Williamson, B. D., Carswell, E. A., Rubin, B. Y. & Prendergast, J. S. Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferons. Proc. Natl Acad. Sci. USA 80, 5397–5401 (1983).
  Article CAS PubMed PubMed Central Google Scholar
• Wallach, D. Preparations of lymphotoxin induce resistance to their own cytotoxic effect. J. Immunol. 132, 2464–2469 (1984).
  CAS PubMed Google Scholar
• Palladino, M. A. Jr et al. Characterization of the antitumor activities of human tumor necrosis factor alpha and the comparison with other cytokines: induction of tumor-specific immunity. J. Immunol. 138, 4023–4032 (1987).
  CAS PubMed Google Scholar
• Kashii, Y., Giorda, R., Herberman, R. B., Whiteside, T. L. & Vujanovic, N. L. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J. Immunol. 163, 5358–5366 (1999).
  CAS PubMed Google Scholar
• Prevost-Blondel, A., Roth, E., Rosenthal, F. M. & Pircher, H. Crucial role of TNF-α in CD8 cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo. J. Immunol. 164, 3645–3651 (2000).
  Article CAS PubMed Google Scholar
• Baxevanis, C. N., Voutsas, I. F., Tsitsilonis, O. E., Tsiatas, D. G. & Papmichail, M. Compromised anti-tumor responses in tumor necrosis factor-α knockout mice. Eur. J. Immunol. 30, 1957–1966 (2000).
  Article CAS PubMed Google Scholar
• Calzascia, T. et al. TNF-α is critical for antitumor but not antiviral T cell immunity in mice. J. Clin. Invest. 117, 3833–3845 (2007).
  CAS PubMed PubMed Central Google Scholar
• Selby, P. et al. Tumour necrosis factor in man: clinical and biological observations. Br. J. Cancer 56, 803–808 (1987).
  Article CAS PubMed PubMed Central Google Scholar
• Creagan, E. T., Kovach, J. S., Moertel, C. G., Frytak, S. & Kvols, L. K. A phase 1 clinical trial of recombinant human tumor necrosis factor. Cancer 62, 2467–2471 (1988).
  Article CAS PubMed Google Scholar
• Kimura, K. et al. Phase 1 study of recombinant human tumor necrosis factor. Cancer Chemother. Pharmacol. 20, 223–229 (1987).
  Article CAS PubMed Google Scholar
• Blick, M., Sherwin, S. A., Rosenblum, M. & Gutterman, J. Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res. 47, 2986–2989 (1987).
  CAS PubMed Google Scholar
• Morice, R. C., Blick, M. B., Ali, M. K. & Gutterman, J. U. Pulmonary toxicity of recombinant tumor necrosis factor (rTNF). Proc. Am. Soc. Clin. Oncol. 6, 29 (1987).
  Google Scholar
• Verhoef, C. et al. Isolated limb perfusion with melphalan and TNF-α in the treatment of extremity sarcoma. Curr. Treat. Options Oncol. 8, 417–427 (2007).
  Article PubMed PubMed Central Google Scholar
• Grunhagen, D. J. et al. Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-α and melphalan for limb-threatening soft tissue sarcoma. Cancer 106, 1776–1784 (2006).
  Article CAS PubMed Google Scholar
• Starnes, C. O. Coley's toxins in perspective. Nature 357, 11–12 (1992).
  Article CAS PubMed Google Scholar
• Spriggs, D., Imamura, K., Rodriguez, C., Horiguchi, J. & Kufe, D. W. Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line. Proc. Natl Acad. Sci. USA 84, 6563–6566 (1987).
  Article CAS PubMed PubMed Central Google Scholar
• Beissert, S. et al. Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: In vivo analysis by in situ hybridization. Proc. Natl Acad. Sci. USA 86, 5064–5086 (1989).
  Article CAS PubMed PubMed Central Google Scholar
• Naylor, M. S., Malik, S. T. A., Stamp, G. W. H., Jobling, T. & Balkwill, F. R. In situ detection of tumour necrosis factor in human ovarian cancer specimens. Eur. J. Cancer 26, 1027–1030 (1990).
  Article CAS PubMed Google Scholar
• Naylor, M. S., Stamp, G. W. H., Foulkes, W. D., Eccles, D. & Balkwill, F. R. Tumor necrosis factor and its receptors in human ovarian cancer. J. Clin. Invest. 91, 2194–2206 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Karayiannakis, A. J. et al. Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients. Anticancer Res. 21, 1355–1358 (2001).
  CAS PubMed Google Scholar
• Yoshida, N. et al. Interleukin-6, tumour necrosis factor α and interleukin-1β in patients with renal cell carcinoma. Br. J. Cancer 86, 1396–1400 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Ferrajoli, A. et al. The clinical significance of tumor necrosis factor-a plasma level in patients having chronic lymphocytic leukemia. Blood 100, 1215–1219 (2002).
  Article CAS PubMed Google Scholar
• Bozcuk, H. et al. Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy. Cytokine 27, 58–65 (2004).
  Article CAS PubMed Google Scholar
• Anderson, G. M., Nakada, M. T. & DeWitte, M. Tumor necrosis factor-α in the pathogenesis and treatment of cancer. Curr. Opin. Pharmacol. 4, 314–320 (2004).
  Article CAS PubMed Google Scholar
• Pfitzenmaier, J. et al. Elevation of cytokine levels in cachectic patients with prostate carcinoma. Cancer 97, 1211–1216 (2003).
  Article CAS PubMed Google Scholar
• Michalaki, V., Syrigos, K., Charles, P. & Waxman, J. Serum levels of IL-6 and TNF-α correlate with clinicopathological features and patient survival in patients with prostate cancer. Br. J. Cancer 91, 1227 (2004).
  Article CAS PubMed Central Google Scholar
• Frater-Schroder, M., Risau, W., Hallmann, R., Gautschi, P. & Bohlen, P. Tumor necrosis factor type α, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl Acad. Sci. USA 84, 5277–5281 (1987).
  Article CAS PubMed PubMed Central Google Scholar
• Leibovich, S. J. et al. Macrophage-induced angiogenesis is mediated by tumour necrosis factor alpha. Nature 329, 630–632 (1987).
  Article CAS PubMed Google Scholar
• Malik, S. T. A., Griffin, D. B., Fiers, W. & Balkwill, F. R. Paradoxical, effects of tumour necrosis factor in experimental ovarian cancer. Int. J. Cancer 44, 918–925 (1989).
  Article CAS PubMed Google Scholar
• Malik, S. T. A., Naylor, S., East, N., Oliff, A. & Balkwill, F. R. Cells secreting tumour necrosis factor show enhanced metastasis in nude mice. Eur. J. Cancer 26, 1031–1034 (1990).
  Article CAS PubMed Google Scholar
• Orosz, P. et al. Enhancement of experimental metastasis by tumor necrosis factor. J. Exp. Med. 177, 1391–1398 (1993).
  Article CAS PubMed Google Scholar
• Kim, S. et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457, 102–106 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Pasparakis, M., Alexopoulou, L., Episkopou, V. & Kollias, G. Immune and inflammatory responses in TNFα-deficient mice: a critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184, 1397–1411 (1996).
  Article CAS PubMed Google Scholar
• Virchow, R. Die krankhaften Geschwulste (1863).
  Google Scholar
• Balkwill, F. & Mantovani, A. Inflammation and cancer: back to Virchow. Lancet 357, 539–545 (2001).
  Article CAS PubMed Google Scholar
• Balkwill, F., Charles, K. A. & Mantovani, A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7, 211–217 (2005).
  Article CAS PubMed Google Scholar
• Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454, 436–444 (2008).
  Article CAS PubMed Google Scholar
• Suganuma, M. et al. Essential role of tumor necrosis factor α (TNF-α) in tumor promotion as revealed by TNF-α-deficient mice. Cancer Res. 59, 4516–4518 (1999).
  CAS PubMed Google Scholar
• Kulbe, H. et al. The inflammatory cytokine TNF-α generates an autocrine tumour-promoting network in epithelial ovarian cancer cells. Cancer Res. 67, 585–592 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Egberts, J.-H. et al. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis. Cancer Res. 68, 1443–1450 (2008).
  Article CAS PubMed Google Scholar
• Stathopoulos, G. T. et al. Tumor necrosis factor-α promotes malignant pleural effusion. Cancer Res. 67, 9825–9834 (2007).
  Article CAS PubMed Google Scholar
• Zins, K., Abraham, D., Sioud, M. & Aharinejad, S. Colon cancer cell-derived tumor necrosis factor-α mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway. Cancer Res. 67, 1038–1045 (2007).
  Article CAS PubMed Google Scholar
• Li, B. et al. Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site. Cancer Res. 69, 338–348 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Hagemann, T. et al. TNF-α dependent increased c-Jun and NF-κB activity in tumour cell lines upon co-cultivation with macrophages. J. Immunol. 175, 1197–1205 (2005).
  Article CAS PubMed Google Scholar
• Hagemann, T. et al. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J. Immunol. 176, 5023–5032 (2006).
  Article CAS PubMed Google Scholar
• Szlosarek, P. W. et al. Expression and regulation of tumor necrosis factor-α in normal and malignant ovarian epithelium. Mol. Cancer Ther. 5, 382–390 (2006).
  Article CAS PubMed Google Scholar
• Galban, S. et al. von Hippel–Lindau protein-mediated repression of tumor necrosis factor alpha translation revealed through use of cDNA arrays. Mol. Cell. Biol. 23, 2316–2328 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Suganuma, M., Kuzuhara, T., Yamaguchi, K. & Fujiki, H. Carcinogenic role of tumor necrosis factor-α inducing protein of Helicobacter pylori in human stomach. J. Biochem. Mol. Biol. 39, 1–8 (2006).
  CAS PubMed Google Scholar
• Maeda, S., Kamata, H., Luo, J. L., Leffert, H. & Karin, M. IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121, 977–990 (2005).
  Article CAS PubMed Google Scholar
• Popivanova, B. K. et al. Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest. 118, 560–570 (2008).
  CAS PubMed PubMed Central Google Scholar
• Oguma, K. et al. Activated macrophages promote Wnt signalling through tumour necrosis factor-α in gastic tumour cells. EMBO J. 27, 1671–1681 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Komori, A. et al. Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res. 53, 1982–1985 (1993).
  CAS PubMed Google Scholar
• Li, J. et al. TNF-α induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells. J. Clin. Invest. 117, 3283–3295 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Yan, B. et al. Tumor necrosis factor-α is a potent endogenous mutagen that promotes cellular transformation. Cancer Res. 66, 11565–11570 (2006).
  Article CAS PubMed Google Scholar
• Babbar, N. & Casero, R. A. Jr. Tumor necrosis factor-α increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for inflammation-induced carcinogenesis. Cancer Res. 66, 11125–11130 (2006).
  Article CAS PubMed Google Scholar
• Komori, J. et al. Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma. Hepatology 47, 888–896 (2008).
  Article CAS PubMed Google Scholar
• Akiyama, M. et al. Nuclear factor-κB p65 mediates tumor necrosis factor α-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res. 63, 18–21 (2003).
  CAS PubMed Google Scholar
• Bates, R. C. & Mercurio, A. M. Tumor necrosis factor-α stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol. Biol. Cell 14, 1790–1800 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Arnott, C. H. et al. Expression of both TNF-a receptor subtypes is essential for optimal skin tumour development. Oncogene 23, 1902–1910 (2004).
  Article CAS PubMed Google Scholar
• Tomita, Y. et al. Spontaneous regression of lung metastasis in the absence of tumour necrosis factor p55. Int. J. Cancer 112, 927–933 (2004).
  Article CAS PubMed Google Scholar
• Kitakata, H. et al. Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells. Cancer Res. 62, 6682–6687 (2002).
  CAS PubMed Google Scholar
• Curiel, T. J. Regulatory T cells and treatment of cancer. Curr. Opin. Immunol. 20, 241–246 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, X., Baumel, M., Mannel, D. N., Howard, O. M. Z. & Oppenheim, J. J. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J. Immunol. 179, 154–161 (2007).
  Article CAS PubMed Google Scholar
• Greten, F. R. et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285–296 (2004).
  Article CAS PubMed Google Scholar
• Liu, Z.-G., Hsu, H., Goeddel, D. V. & Karin, M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565–576 (1996).
  Article CAS PubMed Google Scholar
• Bonizzi, G. & Karin, M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280–288 (2004).
  Article CAS PubMed Google Scholar
• Lee, D.-F. et al. IKKB suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130, 440–455 (2007).
  Article CAS PubMed Google Scholar
• Scott, K. A. et al. An anti-TNF-α antibody inhibits the development of experimental skin tumors. Mol. Cancer Ther. 2, 445–451 (2003).
  CAS PubMed Google Scholar
• Rao, V. P. et al. Proinflammatory CD4+CD45RBhi lymphocytes promote mammary and intestinal carcinogenesis in Apc Min/+ mice. Cancer Res. 66, 57–61 (2006).
  Article CAS PubMed Google Scholar
• Stasi, R., Amadori, S., Newland, A. C. & Provan, D. Infliximab chimeric antitumor necrosis factor-a monoclonal antibody as potential treatment of myelodysplastic syndromes. Leuk. Lymphoma 46, 509–516 (2005).
  Article CAS PubMed Google Scholar
• Nadkarni, S., Mauri, C. & Ehrenstein, M. R. Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β. J. Exp. Med. 204, 33–39 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Zaba, L. C. et al. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 204, 3183–3194 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Langowski, J. L. et al. IL-23 promotes tumour incidence and growth. Nature, 442, 461–465 (2006).
  Article CAS PubMed Google Scholar
• Fujiki, H. et al. New TNF-α releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen. Mut. Res. 523, 119–125 (2003).
  Article CAS Google Scholar
• Bongartz, T. et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies. JAMA 295, 2275–2285 (2006).
  Article CAS PubMed Google Scholar
• Askling, J. & Bongartz, T. Malignancy and biologic therapy in rheumatoid arthritis. Curr. Opin. Rheumatol. 20, 334–339 (2008).
  Article CAS PubMed Google Scholar
• Creagh, E. M. & O'Neill, L. A. J. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 27, 352–357 (2006).
  Article CAS PubMed Google Scholar
• Alexandroff, A. B., Jackson, A. M., O'Donnell, M. A. & James, K. BCG immunotherapy of bladder cancer: 20 years on. Lancet 353, 1689–1694 (1999).
  Article CAS PubMed Google Scholar
• Hagemann, T. et al. 'Re-educating' tumor-associated macrophages by targeting NF-κB. J. Exp. Med. 205, 1261–1268 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Apetoh, L. et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nature Med. 13, 1050–1059 (2007).
  Article CAS PubMed Google Scholar
• Swann, J. B. et al. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc. Natl Acad. Sci. USA 105, 652–656 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Koebel, M. et al. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450, 903–907 (2007).
  Article CAS PubMed Google Scholar
• Senzer, N. et al. TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors. J. Clin. Oncol. 22, 592–601 (2004).
  Article CAS PubMed Google Scholar
• Mauceri, H. J. et al. Translational strategies exploiting TNF-α that sensitize tumors to radiation therapy. Cancer Gene Ther. 31 Oct 2008 (doi:10.1038/cgt.2008.86).
  Article PubMed PubMed Central CAS Google Scholar
• Krippner-Heidenreich, A. et al. Single chain TNF, a TNF derivative with enhanced stability and antitumoral activity. J. Immunol. 180, 8176–8183 (2008).
  Article CAS PubMed Google Scholar
• Petersen, S. L. et al. Autocrine TNFα signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 12, 445–456 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Charles, P. et al. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-α therapy in rheumatoid arthritis. J. Immunol. 163, 1521–1528 (1999).
  CAS PubMed Google Scholar
• Gray-Schopfer, V. C., Karasarides, M., Hayward, R. & Marais, R. Tumor necrosis factor-α blocks apoptosis in melanoma cells when BRAF signaling is inhibited. Cancer Res. 67, 122–129 (2007).
  Article CAS PubMed Google Scholar
• Gordon, G. J. et al. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-a in malignant pleural mesothelioma. J. Pathol. 211, 439–446 (2007).
  Article CAS PubMed Google Scholar
• Varfolomeev, E. E. & Ashkenazi, A. Tumor necrosis factor: an apoptosis JuNKie? Cell 116, 491–497 (2004).
  Article CAS PubMed Google Scholar
• Aggarwal, B. B. Signalling pathways of the TNF superfamily: a double-edged sword. Nature Rev. Immunol. 3, 745–756 (2003).
  Article CAS Google Scholar
• Akira, S. & Takeda, K. Toll-like receptor signalling. Nature Rev. Immunol. 4, 499–511 (2004).
  Article CAS Google Scholar
• Tsenova, L., Bergtold, A., Freedman, V. H., Young, R. A. & Kaplan, G. Tumour necrosis factor α is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc. Natl Acad. Sci. USA 96, 5657–5662 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Schluter, D. et al. Both lymphotoxin-α and TNF are crucial for control of Toxoplasma gondii in the central nervous system. J. Immunol. 170, 6172–6182 (2003).
  Article PubMed Google Scholar
• Pasparakis, M. et al. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc. Natl Acad. Sci. USA 94, 6319–6323 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Kuprash, D. V. et al. Novel tumor necrosis factor-knockout mice that lack Peyer's patches. Eur. J. Immunol. 35, 1592–1600 (2005).
  Article CAS PubMed Google Scholar
• Grivennikov, S. I. et al. Distinct and nonredundant in vivo functions of TNF produced by T cells and macrophages/neutrophils: protective and deleterious effects. Immunity 22, 93–104 (2005).
  CAS PubMed Google Scholar
• Beutler, B. et al. Identity of tumour necrosis factor and the macrophage-secreted factor cachetin. Nature 316, 552–554 (1985).
  Article CAS PubMed Google Scholar
• Brennan, F. M., Jackson, A., Chantry, D., Maini, R. & Feldmann, M. Inhibitory effect of TNF-alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2, 244–247 (1989).
  Article CAS PubMed Google Scholar
• Williams, R. O., Feldmann, M. & Maini, R. N. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl Acad. Sci. USA 89, 9784–9788 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• van Deventer, S. J. Anti-TNF antibody treatment of Crohn's disease. Ann. Rheum. Dis. 58, 14–20 (1999).
  Article Google Scholar
• Mease, P. J. et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356, 385–390 (2000).
  Article CAS PubMed Google Scholar
• Chaudhari, U. et al. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet 357, 1842–1847 (2001).
  Article CAS PubMed Google Scholar
• Berry, M. A. et al. Evidence of a role of tumor necrosis factor α in refractory asthma. N. Engl. J. Med. 354, 697–708 (2006).
  Article CAS PubMed Google Scholar
• Ashkenazi, A. Targeting death and decoy receptors of the tumor necrosis factor superfamily. Nature Rev. Cancer 2, 420–430 (2002).
  Article CAS Google Scholar
• Gray, P. W., Barret, K., Chantry, D., Turner, M. & Feldmann, M. Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein. Proc. Natl Acad. Sci. USA 87, 7380–7384 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Heller, R. A. et al. Amplified expression of tumor necrosis factor receptor in cells transfected with Epstein–Barr virus shuttle vector cDNA libraries. J. Biol. Chem. 265, 5708–5717 (1990).
  Article CAS PubMed Google Scholar
• Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860–867 (2002).
  Article CAS PubMed PubMed Central Google Scholar